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ABSTRACT
Neurological features occur during the later stages of HIV infection. The most common manifestations are 
opportunistic infections like cerebral toxoplasmosis and progressive multifocal leukoencephalopathy, as 
well as malignant lymphomas like primary EBV associated CNS lymphoma. We present a case of a 21-year-
old man, diagnosed as HIV+ in 2010. The patient receives HAART (kivexa/kaletra) from 13.08.2013 to date 
with poor adherence. The current complaints began two weeks ago with weakness in the lower extremities, 
gait disturbances and headache. The neurological examination at the admission time showed no meninge-
al signs, weakened tendon reflexes in left limbs, absent abdominal reflexes, central facial palsy on the left, 
positive Babinski sign. Upon admission to the hospital the patient presented with CD 4-34c/mm³, VL- 2180 
c/ml. Cerebral spinal fluid viral load was <20 c/ml. The results of the serological and virological tests from 
cerebral spinal fluid were: PCR EBV (-); PCR CMV (-); IgM EBV (-); IgG CMV (-); T.gondii IgM (-); IgG(-); 
PCR for pathogenic free-living amoeba (-). MRI: space occupying lesion, interpreted as a lymphoma, MRI 
after 6 months: progression of the lesion. A biopsy of peripheral lymph node showed nonspecific finding. 
The patient was put on patogenetic treatment against cerebral edema, treatment against T. gondii infection 
(clindamycin, co-trimoxazole), and gancyclovir, meronem, fungolon, ART as well. The patient was without 
precise, laboratory confirmed diagnosis, but the general condition is better.
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INTRODUCTION
Most of the neurological manifestations of the 
HIV infection occur in the later stages with the pro-
gression of the immunodeficiency, even though the 
central nervous system can be involved in every stage 
of the HIV infection. 
The most common neurological opportunis-
tic infection is cerebral toxoplasmosis (4). Clinical 
symptoms depend on the localization of lesions. The 
major signs include focal neurological deficit: pa-
resis, speech problems or sensory loss, seizures (8). 
Headache with fever or subfebrile temperatures are 
always suspicious. Meningitis signs, however, are 
less typical. The diagnosis is made by performing a 
MRI. An updated serology should be available for ev-
ery patient. Up to 97% of patients with cerebral toxo-
plasmosis have IgG+ antibodies, and so a negative re-
sult makes toxoplasmosis unlikely. IgM is only rare-
ly positive (4). 
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Similar clinical features in a patient with severe 
immunodeficiency can cause JCV virus infection, 
which results in progressive multifocal leukoenceph-
alopathy (PML) (6). The main focus of the disease is 
the white matter of the cerebral hemispheres, but in 
some cases, the cerebellum, the grey matter may also 
be affected. The clinical signs of the disease include 
cognitive disorders, which may range from mild im-
pairment of concentration to dementia, focal neuro-
logical deficits, mono- and hemiparesis, speech and 
visual deficits, seizures. The best method for estab-
lishing the diagnosis is MRI, which also allows clar-
ification between cerebral toxoplasmosis and lym-
phoma. Lesions are often parieto-occipital or peri-
ventricular, but the cerebellum may also be involved. 
Examination of cerebrospinal fluid is essential. CSF 
should always be tested for JCV, but the negative PCR 
does not exclude the diagnosis (1,3). 
The differential diagnosis include also prima-
ry CNS lymphomas (PCNSL), associated in almost 
100% of the cases with EBV (2). Histological find-
ings are almost always consistent with diffuse large 
cell non-Hodgkin’s lymphomas (7). Different neu-
rological deficits occur depending on the localiza-
tion. Epileptic seizures, personality changes, chang-
es in awareness, headache and focal deficits such as 
paresis are frequent. For establishing the diagnosis is 
necessary to be performed an emergency CT or (bet-
ter) MRI. The most important differential diagnosis 
is cerebral toxoplasmosis. A solitary mass is usually 
more indicative of primary CNS lymphomas, howev-
er 2-4 lesions may be present. More than four lesions 
of a primary CNS lymphomas are rarely found. The 
best method in establishing the diagnosis is MRS, 
which presents a variety of biochemical changes: lac-
tate/lipid peak, increased choline/creatine and re-
duced N-acetylaspartate/creatine ratios in the lesion 
(5,7). Quantitative EBV PCR in the CSF improves the 
diagnostic specificity, although the predictive value 
remains too low for it to be used as an isolated mark-
er for PCNSL (2). 
The differential diagnosis includes cryptococ-
cosis, glioblastoma, metastatic lesions. 
CASE PRESENTATION
A 21-year-old man, intravenous drug user on 
methadone treatment, diagnosed as HIV+ in 2010. 
He had been started on kaletra/viread/emtriva at the 
time of diagnosis, but soon after that was lost to fol-
low-up. In 2013 the patient was started on kivexa/
kaletra (Tabl. 1).
The current complaints began two weeks ago 
with weakness in the lower extremities, gait distur-
bances, headache, weight loss. At the time of admis-
sion the patient was afebrile, with peripheral lymph-
adenomegaly- swollen lymph nodes in the cervical 
area – beneath the sternocleidomastoid muscles, and 
in the right axillary area. The nodes were painless, 
dense, with size 1/1 sm. There were no abnormalities 
in the respiratory and cardiovascular systems. The 
neurological examination showed absent meningeal 
signs, weakened deep tendon reflexes for left extrem-
ities, absent abdominal reflexes, central facial palsy 
on the left, positive Babinski sign.
The laboratory tests showed mild anaemia and 
hypoproteinemia. The patient’s viral load at the ad-
mission was 2180 c/ml, CD 4- 34 c/mm³. A lumbar 
Date CD 4 VL HAART





13.08.2013 34 2180 →Kivexa/Kaletra
08.01.2014 68 1860
Tabl. 1. Tests results
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puncture was performed – with no abnormalities 
(Tabl. 2). The pulmography and abdominal ultra-
sound were also normal. The patient was consulted 
with a haematologist. As a result lymph node biop-
sy was performed without evidence of tumor cells. 
A MRI with MRS was performed. The results: dif-
ferent lesions in the brain parenchyma, the most dis-
tinct is hypointense lesion in right parietal lobe with 
high signal intensity on T1 and T2. There was no ev-
idence of cortical atrophy, CSF spaces had normal 
placement and capacity. The conclusion was: lym-
phoma. The spectroscopy of the patient was also in-
terpreted as lymphoma: significant elevation in cho-
line/creatine ratio and N-acetyl aspartate depression 
(Fig. 1, 2, 3, 4).
Fig. 1. MRI at time of diagnosis: different lesions in the 
brain parenchyma, the most distinct is hypointense lesion in 




VL < 20 c/ml
EBV PCR (-) negative
CMV PCR (-) negative
EBV IgM, IgG (-) negative
CMV IgM, IgG (-) negative
T. gondi IgM, IgG (-) negative
PCR for free-living amoeba (-) negative
Culture of free-living amoeba (-) negative
Tabl. 2. CSF results
Fig. 2. MRS-CSI- chemical shift 3D at time of diagnosis: 
significant elevation in choline/creatine ratio and N-acetyl 
aspartate depression
Fig. 3. MRI- second: on the control MRI scan the known 
from the first MRI scan lesion in the right parietal lobe has 
been enlarged, there is also presence of focal atrophy of the 
frontal and parietal lobes
Fig. 4. MRS- CSI- chemical shift 3D: second scan. Compared 
to the first MRS here we see improvement of the neuronal 
function. The choline rate is reduced, N- acetylaspartate/
creatine ratio is higher than choline/creatine ratio
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Since admission the patient was put on intrave-
nous rehydration. He underwent a course of  man-
nitol treatment, as well as human serum albumin, 
without any result. Because of the suspicion of ce-
rebral toxoplasmosis we started treatment with 
clindamycin and co-trimoxazole. He received also 
a course with ganciclovir, meronem and fungolon. 
In the course of treatment there was an improve-
ment of the clinical condition of the patient, and af-
ter 6 months there was almost a complete recovery of 
the neurological findings. The second MRI was per-
formed 6 months after the beginning of the illness 
and showed enlargement of the lesion in the right pa-
rietal lobe, with presence of focal atrophy in the fron-
tal and parietal lobes.
DISCUSSION
The clinical case presents a HIV+ patient with 
left hemiparesis and lesion in the right parietal lobe. 
There were numerous difficulties in establishing the 
diagnosis. The HIV+ status of the patient, as well as 
the poor adherence to HAART were leading to se-
vere immunodeficiency, which was the reason for a 
reduced immune response. Primary CNS lymphoma 
and cerebral toxoplasmosis are the leading causes of 
focal brain lesions in HIV+ patients. For that reason 
we performed a MRI. That brought us to the diagno-
sis of lymphoma, which we were not able to confirm. 
Unfortunately, the patient was not indicated for brain 
biopsy. In regard to toxoplasmosis, all serological and 
virological tests were negative, which also did not ex-
clude the diagnosis. There was clinical improvement 
as a result of the toxoplasmosis treatment, but the 
MRI showed progression of the disease. We could 
not also confirm some rare possibilities as CMV en-
cephalitis and free-living amoeba encephalitis.
The patient was subjected to a follow up, al-
though for now he remains without a laboratory con-
firmed diagnosis. 
CONCLUSIONS
Establishing a diagnosis of toxoplasmosis is not 
easy, especially in HIV+ patients, because of their se-
vere immunodeficiency. In this case an improvement 
was detected after initiating antitoxoplasmosis treat-
ment. Further, we accept cerebral toxoplasmosis as a 
diagnosis, because of the clinical improvement.
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